Ground breaking new procedures in Europe for assessing the relative effectiveness of new drugs at an EU-level are due to go live from January 2025 and companies must be ready.
In this article, The European Confederation of Pharmaceutical Entrepreneurs’ Alexander Natz and Matias Olsen set out what companies need to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?